Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015
Back to SEC Filings
Material AgreementItem 1.01 · 8-KLOW RiskPositive

HCW Biologics Inc.

The company signed a major contract or deal. An 8-K is the notice a US public company must file within four business days of a major event.

hcwbiologics.com
Filed: Sep 23, 2026MiramarCIK: 0001828673Biotechnology
Full company profileView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

HCW Biologics Inc. secured $1.49 million in funding on September 23, 2026, by issuing 903,614 units to an existing institutional investor through a Securities Purchase Agreement. Each unit includes a pre-funded warrant and a common stock purchase warrant, demonstrating investor confidence in the company's development initiatives.

Key Takeaways

HCW Biologics raised approximately $1.49 million at $1.65 per unit through a securities purchase agreement with an existing institutional investor

The financing structure includes pre-funded warrants and contingent common stock purchase warrants subject to stockholder approval

2 more takeaways

Filing Overview

Form Type8-K
Filing DateSep 23, 2026
Item1.01
CategoryMaterial Agreement
CIK0001828673
Accession #0001493152-26-044078
Risk LevelLOW
SentimentPositive
Signalopportunity
Topics
stock offeringmaterial agreement

What This Means

The company entered into a significant agreement that could materially affect its business. This often signals new partnerships, licensing deals, or major contracts.
View Full Filing on SEC.govBrowse More Filings

HCW Biologics Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

4 screens from a live account. No signup.